earnings
confidence high
sentiment negative
materiality 0.75
Elevance Health cuts FY2025 adjusted EPS guidance to ~$30 on elevated medical costs
Elevance Health, Inc.
2025-Q2 EPS
reported $17.33
vs consensus $9.04
▲ beat
(+91.6%)
- Operating revenue $49.4B (+14.3% YoY); diluted EPS $7.72, adjusted diluted EPS $8.84.
- Benefit expense ratio 88.9% (+260 bps) reflecting higher medical costs in Medicaid and ACA.
- FY2025 GAAP EPS guidance ~$24.10; adjusted EPS guidance ~$30.00 (previously ~$35).
- Health Benefits segment operating gain $1.6B vs $2.1B prior year; margin 3.8% vs 5.8%.
- Returned $2.0B of capital to shareholders YTD; declared $1.71/quarter dividend payable 9/25/25.